JP2009521215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009521215A5 JP2009521215A5 JP2008547140A JP2008547140A JP2009521215A5 JP 2009521215 A5 JP2009521215 A5 JP 2009521215A5 JP 2008547140 A JP2008547140 A JP 2008547140A JP 2008547140 A JP2008547140 A JP 2008547140A JP 2009521215 A5 JP2009521215 A5 JP 2009521215A5
- Authority
- JP
- Japan
- Prior art keywords
- expression level
- measuring
- prognostic
- detecting
- signature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002068 genetic Effects 0.000 claims 5
- 239000003550 marker Substances 0.000 claims 5
- 229920000272 Oligonucleotide Polymers 0.000 claims 4
- 102000004965 antibodies Human genes 0.000 claims 3
- 108090001123 antibodies Proteins 0.000 claims 3
- 238000004393 prognosis Methods 0.000 claims 3
- 229920002676 Complementary DNA Polymers 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 238000004458 analytical method Methods 0.000 claims 2
- 239000002299 complementary DNA Substances 0.000 claims 2
- 230000000306 recurrent Effects 0.000 claims 2
- 108020004999 Messenger RNA Proteins 0.000 claims 1
- 230000000295 complement Effects 0.000 claims 1
- 238000007636 ensemble learning method Methods 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 claims 1
- 229920002106 messenger RNA Polymers 0.000 claims 1
- 102000005614 monoclonal antibodies Human genes 0.000 claims 1
- 108010045030 monoclonal antibodies Proteins 0.000 claims 1
- 230000001537 neural Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000003753 real-time PCR Methods 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
Description
分類木と回帰木(54):これらにおいて、サンプルのクラスを決定するために段階的に従うことができる規則の層別を規定するために変数が用いられる。代表的なプロセスにおいては、特定クラスの出力または識別することができないという特定のステートメントを導く1セットの規則が作成される。分類木の例には、次のようなアルゴリズムのインプリメンテーションがある。
Claims (18)
- CRCの進行を判定する予後サインであって、遺伝子マーカーME2及びFASを含む前記予後サイン。
- 表3、4または表9のいずれか1つの中のサインのいずれか1つから選択される1以上の遺伝子マーカーを更に含む、請求項1記載のサイン。
- CRCの予後を判定する装置であって、その上に2以上の位置を有し、一方の位置はME2のオリゴヌクレオチドに結合するオリゴヌクレオチドを有し、他方の位置はFASのオリゴヌクレオチドに結合するオリゴヌクレオチドを有する基板からなる前記装置。
- 表3、4または表9のいずれか1つから選択される少なくとも1つのその他の遺伝子マーカーを更に含む、請求項3記載の装置。
- 患者におけるCRCの予後を判定する方法であって、
(i)患者からのCRC腫瘍サンプルにおいて、遺伝子マーカーME2及びFASを含む予後サインの発現量を測定し、
(ii)再発および非再発腫瘍サンプルにおける予測サインの発現量に予測方法を適用することにより確立される予測モデルを適用し、
(iii)予後を明らかにする
ステップを含む前記方法。 - 表3、4または表9のいずれか1つから選択される少なくとも1つの更なる遺伝子マーカーの発現量を測定することを更に含む、請求項5記載の方法。
- 前記予測方法が線形モデル、サポートベクターマシン、ニューラルネットワーク、分類木と回帰木、アンサンブル学習法、判別分析、最近傍法、ベイジアンネットワーク、独立成分分析からなる群から選択される、請求項5記載の方法。
- 各遺伝子のmRNAの発現量を検出することにより予後サインの発現量を測定するステップが行われる、請求項5〜7のいずれか1つに記載の方法。
- 各遺伝子のcDNAの発現量を検出することにより予後サインの発現量を測定するステップが行われる、請求項5〜7のいずれか1つに記載の方法。
- 予後サインの発現量を測定するステップが前記cDNAの少なくとも一部に相補的なヌクレオチドを用いて行われる、請求項9記載の方法。
- 予後サインの発現量を測定するステップが順方向プライマーおよび逆方向プライマーを用いるqPCR法を用いて行われる、請求項8記載の方法。
- 予後サインの発現量を測定するステップが請求項3または請求項4記載の装置を用いて行われる、請求項8記載の方法。
- 予後サインの発現量を測定するステップが各マーカーのタンパク質の発現量を検出することにより行われる、請求項5〜7のいずれか1つに記載の方法。
- 予後サインの発現量を測定するステップが各マーカーのペプチドの発現量を検出することにより行われる、請求項5〜7のいずれか1つに記載の方法。
- 前記の検出するステップが各マーカーに対する抗体を用いて行われる、請求項12または請求項13記載の方法。
- 前記の検出するステップがサンドイッチイムノアッセイ法を用いて行われる、請求項12〜14のいずれか1つに記載の方法。
- 前記抗体がモノクローナル抗体である、請求項12〜15のいずれか1つに記載の方法。
- 前記抗体がポリクローナル抗血清である、請求項12〜15のいずれか1つに記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ544432 | 2005-12-23 | ||
NZ544432A NZ544432A (en) | 2005-12-23 | 2005-12-23 | Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS |
PCT/NZ2006/000343 WO2007073220A1 (en) | 2005-12-23 | 2006-12-22 | Prognosis prediction for colorectal cancer |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014103714A Division JP6218141B2 (ja) | 2005-12-23 | 2014-05-19 | 結腸直腸癌の予後予測 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009521215A JP2009521215A (ja) | 2009-06-04 |
JP2009521215A5 true JP2009521215A5 (ja) | 2013-01-10 |
JP5632581B2 JP5632581B2 (ja) | 2014-11-26 |
Family
ID=38188869
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008547140A Expired - Fee Related JP5632581B2 (ja) | 2005-12-23 | 2006-12-22 | 結腸直腸癌の予後予測 |
JP2014103714A Expired - Fee Related JP6218141B2 (ja) | 2005-12-23 | 2014-05-19 | 結腸直腸癌の予後予測 |
JP2015257292A Expired - Fee Related JP6058780B2 (ja) | 2005-12-23 | 2015-12-28 | 結腸直腸癌の予後予測 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014103714A Expired - Fee Related JP6218141B2 (ja) | 2005-12-23 | 2014-05-19 | 結腸直腸癌の予後予測 |
JP2015257292A Expired - Fee Related JP6058780B2 (ja) | 2005-12-23 | 2015-12-28 | 結腸直腸癌の予後予測 |
Country Status (10)
Country | Link |
---|---|
US (3) | US10422005B2 (ja) |
EP (3) | EP2392678B1 (ja) |
JP (3) | JP5632581B2 (ja) |
KR (3) | KR101562644B1 (ja) |
CN (1) | CN101389957B (ja) |
AU (1) | AU2006328023B2 (ja) |
CA (2) | CA2640352C (ja) |
ES (3) | ES2536233T3 (ja) |
NZ (3) | NZ544432A (ja) |
WO (1) | WO2007073220A1 (ja) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2783348B1 (fr) * | 1998-09-15 | 2000-10-13 | Alstom Technology | Methode de discrimination entre un arc interne et un arc de coupure dans un disjoncteur de moyenne ou de haute tension |
CA2563074C (en) | 2004-04-09 | 2014-05-20 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
NZ593225A (en) | 2006-01-11 | 2012-10-26 | Genomic Health Inc | Gene expression markers (CMYC and Ki-67) for colorectal cancer prognosis |
ES2546182T3 (es) * | 2006-07-21 | 2015-09-21 | Epigenomics Ag | Métodos y kits para análisis de metilación en trastornos proliferativos celulares colorrectales |
DE102006035393A1 (de) * | 2006-11-02 | 2008-05-15 | Signature Diagnostics Ag | Prognostische Marker für die Klassifizierung des dreijährigen progessionsfreien Überlebens von Patienten mit Kolonkarzinomen basierend auf Expressionsprofilen von biologischen Proben |
US20080234946A1 (en) * | 2007-03-22 | 2008-09-25 | University Of South Florida | Predictive radiosensitivity network model |
US20090076734A1 (en) | 2007-03-22 | 2009-03-19 | Torres-Roca Javier F | Gene Signature for the Prediction of Radiation Therapy Response |
AU2008300338A1 (en) * | 2007-06-04 | 2009-03-26 | Diagnoplex | Biomarker combinations for colorectal cancer |
NZ562237A (en) * | 2007-10-05 | 2011-02-25 | Pacific Edge Biotechnology Ltd | Proliferation signature and prognosis for gastrointestinal cancer |
ES2332557B1 (es) | 2007-12-04 | 2011-02-02 | Universidad Autonoma De Madrid | Huella genomica para el pronostico de la evolucion de adenocarcinoma colorectal. |
CN102388305B (zh) * | 2009-02-02 | 2014-11-19 | 罗格斯新泽西州立大学 | 基于图像的风险分数-来自数字组织病理学的存活率和结果的预后预估 |
WO2010127322A1 (en) | 2009-05-01 | 2010-11-04 | Genomic Health Inc. | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy |
WO2011006642A1 (en) | 2009-07-16 | 2011-01-20 | Roche Diagnostics Gmbh | Flap endonuclease-1 as a marker for cancer |
US8445271B2 (en) | 2010-05-03 | 2013-05-21 | Enzo Life Sciences, Inc. | Processes and kits for determining multi-drug resistance of cells |
WO2011140662A1 (en) * | 2010-05-13 | 2011-11-17 | The Royal Institution For The Advancement Of Learning / Mcgill University | Cux1 signature for determination of cancer clinical outcome |
EP2576815B1 (en) * | 2010-06-04 | 2018-02-14 | Biomérieux | Method for the prognosis of colorectal cancer |
WO2012019154A2 (en) * | 2010-08-06 | 2012-02-09 | Beth Israel Deaconess Medical Center | Methods and compositions for malic enzyme 2 (me2) as a target for cancer therapy |
KR101401561B1 (ko) * | 2010-12-30 | 2014-06-11 | 주식회사 바이오인프라 | 복합 바이오마커를 활용한 암 진단 정보 생성 방법, 및 암 진단 예측 시스템 장치 |
US20120184454A1 (en) * | 2011-01-14 | 2012-07-19 | Kalady Matthew F | Gene signature is associated with early stage rectal cancer recurrence |
CN102183662A (zh) * | 2011-03-22 | 2011-09-14 | 浙江大学 | 一种大肠癌预后预测模型的建立方法 |
CN104053788A (zh) * | 2011-11-28 | 2014-09-17 | 加泰罗尼亚调查和高级研究机构 | 结肠直肠癌的预后方法和试剂盒 |
US9977033B2 (en) * | 2012-09-11 | 2018-05-22 | The Board Of Regents Of The University Of Texas System | Methods for assessing cancer recurrence |
KR20160045547A (ko) * | 2014-10-17 | 2016-04-27 | 에스케이텔레콤 주식회사 | 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법 |
CN105021828B (zh) * | 2015-07-20 | 2017-07-28 | 上海交通大学医学院附属新华医院 | 通过检测三期结直肠肿瘤患者血清预测肿瘤患者预后 |
EP3411505A4 (en) | 2016-02-02 | 2020-01-15 | Guardant Health, Inc. | DETECTION AND DIAGNOSIS OF CANCER EVOLUTION |
WO2017143322A1 (en) * | 2016-02-18 | 2017-08-24 | University Of South Florida | Materials and methods for detecting cancer based on urinary levels of rhamm |
US11164082B2 (en) | 2017-02-28 | 2021-11-02 | Anixa Diagnostics Corporation | Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis |
US10360499B2 (en) * | 2017-02-28 | 2019-07-23 | Anixa Diagnostics Corporation | Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis |
US9934364B1 (en) | 2017-02-28 | 2018-04-03 | Anixa Diagnostics Corporation | Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis |
AU2018282865A1 (en) * | 2017-06-13 | 2019-12-19 | Bostongene Corporation | Systems and methods for generating, visualizing and classifying molecular functional profiles |
AU2018364001A1 (en) * | 2017-11-09 | 2020-06-25 | National University Corporation Tokyo Medical And Dental University | Inhibitor of the expression of cancer-promoting factors, screening method for active ingredient thereof, expression cassette useful in said method, diagnostic drug, and diagnostic method |
WO2019154884A1 (en) * | 2018-02-07 | 2019-08-15 | Ecole Polytechnique Federale De Lausanne (Epfl) | Method for determining cancer invasiveness and patient prognosis |
WO2019173233A1 (en) * | 2018-03-05 | 2019-09-12 | Anixa Diagnostics Corporation | Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis |
TW202018727A (zh) | 2018-11-09 | 2020-05-16 | 財團法人工業技術研究院 | 整體式學習預測方法與系統 |
CN111321221B (zh) * | 2018-12-14 | 2022-09-23 | 中国医学科学院肿瘤医院 | 用于预测直肠癌局部切除手术后复发风险的组合物、微阵列和计算机系统 |
CN109599181B (zh) * | 2019-01-09 | 2021-04-16 | 中国医学科学院肿瘤医院 | 一种在治疗前针对t3-larc患者的生存预测系统及预测方法 |
EP3935581A4 (en) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING |
CN109811057B (zh) * | 2019-03-27 | 2022-02-22 | 中山大学附属第六医院 | 缺氧相关基因在结直肠癌预测系统中的应用 |
CN109762907B (zh) * | 2019-03-27 | 2022-02-22 | 中山大学附属第六医院 | 缺氧相关基因在预测i/ii期结直肠癌的试剂盒中的应用 |
US11154240B2 (en) | 2019-04-02 | 2021-10-26 | Kpn Innovations Llc | Methods and systems for utilizing diagnostics for informed vibrant constitutional guidance |
CN110246591B (zh) * | 2019-07-15 | 2021-11-05 | 中国中医科学院西苑医院 | 一种中医药治疗人群的预后预测系统 |
CN112342295A (zh) * | 2019-08-06 | 2021-02-09 | 中山大学孙逸仙纪念医院 | 一种检测人结直肠癌的肿瘤标志物及其应用 |
CN110791565B (zh) * | 2019-09-29 | 2021-09-03 | 浙江大学 | 一种用于ii期结直肠癌复发预测的预后标记基因及随机生存森林模型 |
US11725048B2 (en) | 2019-12-20 | 2023-08-15 | Hudson Institute of Medical Research | CXCL10 binding proteins and compositions thereof |
US12020417B2 (en) * | 2020-04-24 | 2024-06-25 | Camtek Ltd. | Method and system for classifying defects in wafer using wafer-defect images, based on deep learning |
US11289206B2 (en) | 2020-06-02 | 2022-03-29 | Kpn Innovations, Llc. | Artificial intelligence methods and systems for constitutional analysis using objective functions |
US11211158B1 (en) | 2020-08-31 | 2021-12-28 | Kpn Innovations, Llc. | System and method for representing an arranged list of provider aliment possibilities |
CN112301131B (zh) * | 2020-11-13 | 2021-10-26 | 中国医学科学院基础医学研究所 | Rnf138作为预测结直肠癌对sc75741治疗敏感性的生物标志物的应用 |
CN113591919B (zh) * | 2021-06-29 | 2023-07-21 | 复旦大学附属中山医院 | 基于ai对早期肝细胞癌术后复发预后的分析方法及系统 |
WO2023128419A1 (ko) * | 2021-12-31 | 2023-07-06 | 주식회사 이노제닉스 | 대장암 및 대장 용종 또는 진행 선종의 선별 방법 및 그 응용 |
IT202200001817A1 (it) | 2022-02-02 | 2023-08-02 | Aizoon S R L | Procedimento per la prognosi di una malattia in seguito ad un trattamento terapeutico, relativo sistema e prodotto informatico |
CN114652814B (zh) * | 2022-03-11 | 2023-02-03 | 郑州大学第一附属医院 | 一种免疫检查点抑制剂及应用 |
IT202200005861A1 (it) | 2022-03-24 | 2023-09-24 | Aizoon S R L | Procedimento per stimare una variabile di interesse associata ad una data malattia in funzione di una pluralità di diversi dati omici, relativo dispositivo e prodotto informatico |
AU2023208071A1 (en) | 2022-07-25 | 2024-02-08 | Aizoon S.r.l. | Method for providing a clinical decision support, corresponding system for providing a clinical decision support, and computer program product |
CN115938590B (zh) * | 2023-02-09 | 2023-05-02 | 四川大学华西医院 | 结直肠癌术后lars预测模型的构建方法及预测系统 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
GB9805918D0 (en) * | 1998-03-19 | 1998-05-13 | Nycomed Amersham Plc | Sequencing by hybridisation |
EP1163524A2 (en) * | 1999-03-15 | 2001-12-19 | EOS Biotechnology, Inc. | Methods of screening for colorectal cancer modulators |
AU2001278900A1 (en) | 2000-07-18 | 2002-01-30 | Kvh Industries, Inc. | Method of incorporating optical material into an optical fiber |
US20030077568A1 (en) * | 2000-09-15 | 2003-04-24 | Gish Kurt C. | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
JP2004532622A (ja) * | 2001-02-27 | 2004-10-28 | イオス バイオテクノロジー,インコーポレイティド | 転移性結腸直腸癌の新規診断法、組成物及び転移性結腸直腸癌のモジュレーターをスクリーニングする方法 |
US20040191782A1 (en) * | 2003-03-31 | 2004-09-30 | Yixin Wang | Colorectal cancer prognostics |
CA2526878A1 (en) * | 2003-04-08 | 2004-10-21 | Colotech A/S | A method for detection of colorectal cancer in human samples |
EP2481814A3 (en) * | 2003-06-09 | 2012-10-10 | The Regents of the University of Michigan | Compositions and methods for treating and diagnosing cancer |
US20050048494A1 (en) * | 2003-08-28 | 2005-03-03 | Yixin Wang | Colorectal cancer prognostics |
CA2592504A1 (en) * | 2003-12-27 | 2005-07-14 | Aros Applied Biotechnology Aps | Classification of cancer |
-
2005
- 2005-12-23 NZ NZ544432A patent/NZ544432A/en unknown
-
2006
- 2006-12-22 KR KR1020087018020A patent/KR101562644B1/ko active IP Right Grant
- 2006-12-22 CA CA2640352A patent/CA2640352C/en not_active Expired - Fee Related
- 2006-12-22 NZ NZ597363A patent/NZ597363A/xx unknown
- 2006-12-22 ES ES11172587.5T patent/ES2536233T3/es active Active
- 2006-12-22 CN CN2006800529023A patent/CN101389957B/zh not_active Expired - Fee Related
- 2006-12-22 KR KR1020137023872A patent/KR101530689B1/ko active IP Right Grant
- 2006-12-22 KR KR1020147036584A patent/KR101579934B1/ko active IP Right Grant
- 2006-12-22 AU AU2006328023A patent/AU2006328023B2/en not_active Ceased
- 2006-12-22 JP JP2008547140A patent/JP5632581B2/ja not_active Expired - Fee Related
- 2006-12-22 EP EP11172587.5A patent/EP2392678B1/en not_active Not-in-force
- 2006-12-22 CA CA3015335A patent/CA3015335A1/en not_active Abandoned
- 2006-12-22 ES ES11172410.0T patent/ES2484702T3/es active Active
- 2006-12-22 EP EP06835771.4A patent/EP1977237B1/en not_active Not-in-force
- 2006-12-22 NZ NZ586616A patent/NZ586616A/en unknown
- 2006-12-22 EP EP11172410.0A patent/EP2371972B1/en not_active Not-in-force
- 2006-12-22 ES ES06835771.4T patent/ES2525219T3/es active Active
- 2006-12-22 WO PCT/NZ2006/000343 patent/WO2007073220A1/en active Application Filing
-
2008
- 2008-06-20 US US12/214,782 patent/US10422005B2/en not_active Expired - Fee Related
-
2014
- 2014-05-19 JP JP2014103714A patent/JP6218141B2/ja not_active Expired - Fee Related
-
2015
- 2015-09-21 US US14/860,024 patent/US20160068916A1/en not_active Abandoned
- 2015-12-28 JP JP2015257292A patent/JP6058780B2/ja not_active Expired - Fee Related
-
2019
- 2019-08-27 US US16/552,737 patent/US11180815B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009521215A5 (ja) | ||
Luchini et al. | ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach | |
Chen et al. | Gene expression patterns in human liver cancers | |
Ahn et al. | PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy | |
Stearman et al. | Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model | |
O'Brien et al. | CENP‐F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer | |
Brody et al. | High-content affinity-based proteomics: unlocking protein biomarker discovery | |
Fang et al. | Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival | |
JP2009504142A5 (ja) | ||
Ma et al. | Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment | |
JP2014508298A5 (ja) | ||
Lee et al. | Multiplex giant magnetoresistive biosensor microarrays identify interferon-associated autoantibodies in systemic lupus erythematosus | |
JP2011526693A (ja) | 転移に関連する徴候および決定因子、ならびにそれらの使用方法 | |
Huang et al. | A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index | |
RU2012148125A (ru) | Биомаркеры на основе мультиракового ассоциированного с инвазией механизма | |
Zhang et al. | A systems biology-based classifier for hepatocellular carcinoma diagnosis | |
Allison | Prognostic and predictive parameters in breast pathology: a pathologist's primer | |
Jung et al. | Chemokine growth‐regulated oncogene 1 as a putative biomarker for gastric cancer progression | |
Jiang et al. | Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression | |
Theile et al. | Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma | |
Ao et al. | Evaluating hepatocellular carcinoma cell lines for tumour samples using within‐sample relative expression orderings of genes | |
JP2016535270A5 (ja) | ||
Morley-Bunker et al. | Assessment of intra-tumoural colorectal cancer prognostic biomarkers using RNA in situ hybridisation | |
Yaghoobi et al. | Advances in quantitative immunohistochemistry and their contribution to breast cancer | |
Herold et al. | Biosensors and molecular technologies for cancer diagnostics |